Kent Life Science

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 1, 2022	Centauri Therapeutics	$33.0M Series A	—	Boehringer Ingelheim Venture Fund, Animatrix Capital, Johannes Zanzinger, Karen Lackey, Camilla Petrycer Hansen, Wren Capital

Total Raised

N/A

Valuation

N/A